# FDA Inspection 1257425 - Dilawar Ajani, M.D., P.I. - December 16, 2024

Source: https://www.keypedia.com/records/fda_inspections/dilawar-ajani-md-pi/849c27b3-4f71-42d7-99de-ca8df74f204d
Source feed: FDA_Inspections

> FDA Inspection 1257425 for Dilawar Ajani, M.D., P.I. on December 16, 2024. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1257425
- Company Name: Dilawar Ajani, M.D., P.I.
- Inspection Date: 2024-12-16
- Product Type: Human Drugs
- Office Name: Dallas District Office

## Related Documents

- [FDA Inspection 1257425 - 2024-12-16](https://www.keypedia.com/records/fda_inspections/dilawar-ajani-md-pi/0e054ac2-ca41-450e-9ae4-a009f14e64ac)
- [FDA Inspection 1020814 - 2017-07-17](https://www.keypedia.com/records/fda_inspections/dilawar-ajani-md-pi/75d3f726-4421-4171-bf8b-a2f65397e7de)
- [FDA Inspection 542315 - 2008-10-16](https://www.keypedia.com/records/fda_inspections/dilawar-ajani-md-pi/e1daccfe-1159-450f-aaa7-8de36ee24d6a)

Company: https://www.keypedia.com/companies/dilawar-ajani-md-pi/a28e4f2b-94f3-47c3-8695-01c6065289f7

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9